Hirsutism and the effectiveness of spironolactone in its management

@article{McMullen1993HirsutismAT,
  title={Hirsutism and the effectiveness of spironolactone in its management},
  author={Grace McMullen and Andr{\'e} J. Van Herle},
  journal={Journal of Endocrinological Investigation},
  year={1993},
  volume={16},
  pages={925-932}
}

Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.

Feminizing GAHT appears to carry a low risk profile for most patients; however, further research describing the risks of hormone management around the time of gender-affirming surgery and in the aging TGD population is needed to optimize GAHT in the context of the evolving health risks over a TGD patient's lifespan.

[Results of Open-Label non-Randomized Comparative Clinical Trial: "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)].

The combination of bromhexine with spironolactone appeared effective in treating a new coronavirus infection by achieving a faster normalization of the clinical condition, lowering the temperature one and a half times faster, and reducing explanatory combine endpoint the viral load or long duration of hospitalization.

Результаты открытого проспективного контролируемого сравнительного исследования по лечению новой коронавирусной инфекции (COVID-19): Бромгексин И Спиронолактон для лечения КоронаВирусной Инфекции, Требующей госпитализации (БИСКВИТ)

The combination of bromhexine with spironolactone appeared effective in treating a new coronavirus infection by achieving a faster normalization of the clinical condition, lowering the temperature one and a half times faster, and reducing explanatory combine endpoint the viral load or long duration of hospitalization.

Drug utilization pattern during pregnancy in Nekemte referral hospital: a cross sectional study

Many pregnant women were found using drugs during pregnancy in Nekemte referral hospital, including potentially harmful drugs, and there should be intensive assessment of pregnant women treatment in line with the US food and drug administration agency (FDA) risk category and locally operating regulations.

Medical Treatment of Hirsutism in Women

The use of a logical combination of different options has been shown to achieve a satisfactory result in most cases, since systemic therapy reduces hair growth in less than 50% of cases, hirsute women frequently require cosmetic measures.

Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.

There is some evidence to show that spironolactone is an effective treatment to decrease the degree of hirsutism but there was no evidence for effectiveness for the treatment of acne vulgaris.

A Comparative Study of Diane‐35 plus Spironolactone and Diane ‐35 Plus Finasteride in Cases of Hirsutism and Acne

Diane 35 plus spironolactone and Diane 35 plus finasteride are equally effective and safe in the treatment of hirsutism and acne and it is recommended that the treatment period be over 12 months.

Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: A randomised controlled study

Flutamide and spironolactone plus CPA/EE are effective drugs in the treatment of hirsutism and total cholesterol levels decreased significantly but no significant change was observed in any other lipid parameters or in the patients’ hormone profiles.

TRATAMIENTO DEL SÍNDROME DE OVARIO POLIQUÍSTICO. ANTIANDRÓGENOS

A C E T A T O D E C I P R O T E R O N A El a c e t a t o de c i p r o t e r o n a es un e s t e r o i d e d e r i v a d o de la 17 a h i d r o x i p r o g e s t e r o n a con acc ion p r o g e s t a

References

SHOWING 1-10 OF 61 REFERENCES

Evidence for a Role of Androgens in Follicular Maturation

In hypophysectomized immature female rats (HIFR), the ovarian weight response to subcutaneously implanted diethylstilbestrol capsules (DESC) is inhibited by small doses of human chorionic

Treatment of Idiopathic Hirsutism with Spironolactone

The effect of spironolactone in a low dose (50 mg/day) on hirsutism in 21 women was investigated in an open study. A beneficial effect of treatment was obtained in 15 patients (71%).

Gynecomastia During Therapy with Spironolactone

It has been pointed out that there is an increased secretion of aldosterone in patients who have the nephrotic syndrome, and any increase in dosage of the hormone should be considered.

ORAL PROGESTATIONAL ACTIVITY OF SPIRONOLACTONE1

Data from this study are consistent with the menstrual irregularity and amenorrhea seen in women during treatment with spironolactone.

Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.

Results clearly show that the peripherical response (the hair) to the therapy is only just sufficient, and corresponds to a good reduction of the androgenic hormones in blood, and it is not thought this therapy is more advisable than other ones.

Aldosteronism in hypertension. The spironolactone response test.

Excerpt The demonstration of low plasma renin activity (PRA) and increased aldoestrone secretory rate (ASR) may not be sufficient to distinguish primary aldosteronism due to an aldosterone secretor...

THE EFFECT OF SPIRONOLACTONE ON HIRSUTISM AND FEMALE ANDROGEN METABOLISM

Although spironolactone was not consistently successful, it may represent effective therapy for a sub group of patients with hirsutism and there was subjective benefit in hair growth and greasiness and a significant reduction in the semi‐objective Ferriman‐Gallwey index.
...